CA2064575A1 - Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same - Google Patents

Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same

Info

Publication number
CA2064575A1
CA2064575A1 CA002064575A CA2064575A CA2064575A1 CA 2064575 A1 CA2064575 A1 CA 2064575A1 CA 002064575 A CA002064575 A CA 002064575A CA 2064575 A CA2064575 A CA 2064575A CA 2064575 A1 CA2064575 A1 CA 2064575A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
blue
glycosaminoglycans
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002064575A
Other languages
English (en)
French (fr)
Inventor
Michael N. Chang
Shmuel Ben-Sasson
Dan Eilat
John R. Regan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2064575A1 publication Critical patent/CA2064575A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CA002064575A 1989-08-14 1990-08-14 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same Abandoned CA2064575A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39387389A 1989-08-14 1989-08-14
US393,873 1989-08-14

Publications (1)

Publication Number Publication Date
CA2064575A1 true CA2064575A1 (en) 1991-02-15

Family

ID=23556596

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002064575A Abandoned CA2064575A1 (en) 1989-08-14 1990-08-14 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same

Country Status (6)

Country Link
EP (1) EP0489102A4 (ja)
JP (1) JPH05503506A (ja)
AU (1) AU649963B2 (ja)
CA (1) CA2064575A1 (ja)
IL (1) IL95353A (ja)
WO (1) WO1991003226A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571506A (en) * 1989-08-14 1996-11-05 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
FR2672214A1 (fr) * 1991-01-31 1992-08-07 Rhone Poulenc Rorer Sa Application de polymeres biologiquement actifs, pour l'obtention d'un medicament pour le traitement d'infections a retrovirus.
EP0585371B1 (en) * 1991-05-20 2002-04-17 Rhone-Poulenc Rorer International (Holdings) Inc. Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
US6020374A (en) * 1998-05-14 2000-02-01 Ramot University Authority For Applied Research & Industrial Development Ltd. Biologically active synthetic dye compounds
WO2001093871A1 (fr) * 2000-06-07 2001-12-13 Cardiovascular Institute, Ltd. Medicaments pour la prevention de la reangiostenose
US6528037B2 (en) 2000-10-11 2003-03-04 Telik, Inc. Method for determining whether a compound is an insulin receptor kinase activator
AU2003242054A1 (en) * 2003-06-09 2005-01-04 Cardiovascular Institute, Ltd. Stem cell invasion inhibitor
WO2007131813A1 (de) 2006-05-17 2007-11-22 Basf Se Kondensationsprodukte, verfahren zu deren herstellung und deren verwendung in arzneimitteln, als desinfektionsmittel oder als gerbstoff
CN111035630B (zh) * 2020-01-14 2022-06-17 宁波大学 调控人胰岛蛋白聚集状态的方法及二型糖尿病的治疗预防药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
EP0354714A3 (en) * 1988-08-12 1991-04-10 Hadassah Medical Organization Pharmaceutical compositions containing polyaromatic compounds
IL87444A0 (en) * 1988-08-12 1989-01-31 Hadassah Med Org Pharmaceutical compositions containing polyaromatic compounds

Also Published As

Publication number Publication date
IL95353A (en) 1995-01-24
AU6337590A (en) 1991-04-08
EP0489102A4 (en) 1992-08-12
IL95353A0 (en) 1991-06-30
AU649963B2 (en) 1994-06-09
JPH05503506A (ja) 1993-06-10
WO1991003226A2 (en) 1991-03-21
WO1991003226A3 (en) 1991-05-30
EP0489102A1 (en) 1992-06-10

Similar Documents

Publication Publication Date Title
CA2132150C (en) Antiulcer agent and adhesion inhibitor for helicobacter pyroli
RU2383554C2 (ru) Сложные эфиры гиалуроновой кислоты с реином, способ их получения и композиции, содержащие эти эфиры
US5560935A (en) Physiologically active substances extracted from activated tissues
JPH09510493A (ja) 新規なヘパリン様硫酸化多糖類
JPH06507635A (ja) 病理学的過程の予防および／または治療用組成物
CA2064575A1 (en) Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
JP2003501381A (ja) 関節炎の処置
US4710493A (en) Therapeutic agent for the use in cancer treatment
US6608043B1 (en) Remedies for joint diseases
US7005426B2 (en) Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active component
US4510135A (en) Orally administered heparin
EP0354714A2 (en) Pharmaceutical compositions containing polyaromatic compounds
JP3149180B2 (ja) 瘢痕治療のためのカルシウム拮抗薬の使用
GB2078768A (en) Modified glucosaminoglycans having antilipemic activity and essentially devoid of anticoagulant activity
EP0585371B1 (en) Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
AU658133B2 (en) Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same
CN110711191A (zh) 华法林与维生素c的分子复合物,其制备,活性和应用
EP1046397A2 (en) Novel bioactivating substance
EP0354818A2 (en) Pharmaceutical compositions containing polyaromatic compounds as active ingredient and their use
EP3941948B1 (en) Stabilisation and controlled-release systems for medicaments unstable on sterilisation
RU2112542C1 (ru) Препарат для лечения патологических состояний соединительной ткани
US5674482A (en) Polymers with alkyl- or heteroalkyl -aryl backbone and pharmaceutical compositions incorporating same
AU2006203314A1 (en) A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
CS265558B1 (cs) Polysfrový ester glykoseminoglykanu, respektive jeho sodná sůl a způsob výroby těchto látek
WO2014164723A1 (en) Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications

Legal Events

Date Code Title Description
FZDE Discontinued